BCL2 and acute myeloid leukemia: This is the first study in which the expression of BCL2, BAX, BAX/BCL2 ratio and ABCB1 was examined solely in AML-NK group of patients in which the prognostic influence of cytogenetic aberration, either unfavorable or favorable, could be excluded.